# The PERSEVERE Study

Study · id `cardio:ct-nct06588634` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06588634](<https://clinicaltrials.gov/study/NCT06588634>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06588634

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT06588634. Randomized; no masking; primary purpose treatment. Start 2024-12-16 (actual); primary completion 2027-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT06588634, source copy `cardio:ctgov-nct06588634-2026-11-10`, retrieved 2026-11-18)
- Started: 2024-12-16 (actual) (ClinicalTrials.gov record NCT06588634, source copy `cardio:ctgov-nct06588634-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2027-11 (anticipated) (ClinicalTrials.gov record NCT06588634, source copy `cardio:ctgov-nct06588634-2026-11-10`, retrieved 2026-11-18)
- Completion: 2028-02 (anticipated) (ClinicalTrials.gov record NCT06588634, source copy `cardio:ctgov-nct06588634-2026-11-10`, retrieved 2026-11-18)
- Countries: United States; France; Germany; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT06588634, source copy `cardio:ctgov-nct06588634-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06588634-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: The PERSEVERE Study
- Condition: Pulmonary Embolism
- Condition: Pulmonary Thromboembolism
- Intervention (Device): FlowTriever System
- Intervention (Procedure): Standard of Care
- Lead sponsor: Inari Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Inari Medical (`cardio:org-inari-medical`)

## Provenance

Content hash: 035cba0e7f70079038c1916d4d161440097531df16964a70d6397794147b83ee
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
